Home › Funds › D. E. Shaw & Co › GRCE
D. E. Shaw & Co position in GRCE
GRACE THERAPEUTICS INC · Health Care
Latest position (Q4 2024)27.33M sh
Reported value held$26.16M
Portfolio Weight0.02%
First reportedQ1 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 34.36M | $42.38M | New |
| Q2 2023 | 34.36M | $36.26M | Hold |
| Q3 2023 | 38.12M | $30.65M | Add |
| Q4 2023 | 38.12M | $28.97M | Hold |
| Q1 2024 | 38.12M | $28.12M | Hold |
| Q2 2024 | 40.62M | $26.71M | Add |
| Q3 2024 | 17.23M | $14.71M | Reduce |
| Q4 2024 | 27.33M | $26.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GRCE
- Vanguard Group 423.98K sh · $1.48M · Q4 2025
- Bank of America Corp 494.70K sh · $1.12M · Q2 2026
- Two Sigma Investments 96.89K sh · $219.94K · Q2 2026
- Citadel Advisors 52.50K sh · $119.17K · Q2 2026
- BlackRock Inc 37.53K sh · $85.20K · Q2 2026
- UBS Group AG 16.78K sh · $38.08K · Q2 2026
- Morgan Stanley 9.45K sh · $21.45K · Q2 2026
- Wells Fargo & Co 1.80K sh · $4.09K · Q2 2026